MDXH Intrinsic Valuation and Fundamental Analysis - MDxHealth SA - Alpha Spread
M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 2.63 USD 2.33% Market Closed
Market Cap: 71.8m USD
Have any thoughts about
MDxHealth SA?
Write Note

Intrinsic Value

MDXH's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one MDXH stock under the Base Case scenario is 13.11 USD. Compared to the current market price of 2.63 USD, MDxHealth SA is Undervalued by 80%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDXH Intrinsic Value
13.11 USD
Undervaluation 80%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation Backtest
MDxHealth SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MDXH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MDXH?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about MDxHealth SA

Provide an overview of the primary business activities
of MDxHealth SA.

What unique competitive advantages
does MDxHealth SA hold over its rivals?

What risks and challenges
does MDxHealth SA face in the near future?

Has there been any significant insider trading activity
in MDxHealth SA recently?

Summarize the latest earnings call
of MDxHealth SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MDxHealth SA.

Provide P/S
for MDxHealth SA.

Provide P/E
for MDxHealth SA.

Provide P/B
for MDxHealth SA.

Show me price targets
for MDxHealth SA made by professional analysts.

What are the Revenue projections
for MDxHealth SA?

How accurate were the past Revenue estimates
for MDxHealth SA?

What are the Net Income projections
for MDxHealth SA?

How accurate were the past Net Income estimates
for MDxHealth SA?

What are the EPS projections
for MDxHealth SA?

How accurate were the past EPS estimates
for MDxHealth SA?

What are the EBIT projections
for MDxHealth SA?

How accurate were the past EBIT estimates
for MDxHealth SA?

Compare the revenue forecasts
for MDxHealth SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MDxHealth SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MDxHealth SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of MDxHealth SA compared to its peers.

Compare the P/E ratios
of MDxHealth SA against its peers.

Discuss the investment returns and shareholder value creation
comparing MDxHealth SA with its peers.

Analyze the financial leverage
of MDxHealth SA compared to its main competitors.

Show all profitability ratios
for MDxHealth SA.

Provide ROE
for MDxHealth SA.

Provide ROA
for MDxHealth SA.

Provide Net Margin
for MDxHealth SA.

Show all solvency ratios
for MDxHealth SA.

What is the historical Revenue growth
over the last 5 years for MDxHealth SA?

What is the historical Net Income growth
over the last 5 years for MDxHealth SA?

What is the current Free Cash Flow
of MDxHealth SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for MDxHealth SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
MDxHealth SA

Cash & Short-Term Investments 21.3m
PP&E 9.5m
Long-Term Investments 1.3m
Other Assets 98.7m
Long Term Debt 54.4m
Other Liabilities 85.3m

Wall St
Price Targets

MDXH Price Targets Summary
MDxHealth SA

Wall Street analysts forecast MDXH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDXH is 8.98 USD with a low forecast of 6.06 USD and a high forecast of 15.75 USD.

Lowest
Price Target
6.06 USD
130% Upside
Average
Price Target
8.98 USD
241% Upside
Highest
Price Target
15.75 USD
499% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MDXH?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for MDXH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about MDXH dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

MDXH Price
MDxHealth SA

1M 1M
-23%
6M 6M
+5%
1Y 1Y
-7%
3Y 3Y
-78%
5Y 5Y
-78%
10Y 10Y
-78%
Annual Price Range
2.63
52w Low
2.2
52w High
4.48
Price Metrics
Average Annual Return -25.45%
Standard Deviation of Annual Returns 9.11%
Max Drawdown -82%
Shares Statistics
Market Capitalization 71.8m USD
Shares Outstanding 27 288 100
Percentage of Shares Shorted 0.08%

Competitive Landscape

Ownership

MDXH Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

MDxHealth SA

Country

Belgium

Industry

Biotechnology

Market Cap

71.8m USD

Dividend Yield

0%

Description

MDxHealth SA engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. The company is headquartered in Herstal, Liege. The company went IPO on 2006-06-26. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The firm's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.

Contact

LIEGE
Herstal
CAP Business Center, Rue d'Abhooz 31
+3242577021.0
mdxhealth.com

IPO

2006-06-26

Employees

177

Officers

See Also

Discover More
What is the Intrinsic Value of one MDXH stock?

The intrinsic value of one MDXH stock under the Base Case scenario is 13.11 USD.

Is MDXH stock undervalued or overvalued?

Compared to the current market price of 2.63 USD, MDxHealth SA is Undervalued by 80%.

Back to Top